Home / Press Release / Global Cardiopulmonary Stress Testing Systems Market Expected to Grow At a CAGR of 4.8% During the Forecast Period

Global Cardiopulmonary Stress Testing Systems Market Expected to Grow At a CAGR of 4.8% During the Forecast Period

The latest market report published by Credence Research, Inc. “Cardiopulmonary Stress Testing Systems Market: Growth, Future Prospects, and Competitive Analysis, 2019 - 2027” the cardiopulmonary stress testing systems market was valued at US$ 2,256.8 Mn in 2018, expected to grow at a CAGR of 4.8% during the forecast period from 2019 to 2027. 

Market Insights 

The global cardiopulmonary stress testing systems market is growing effectively from 2019 to 2027 accredited to the rise in interest for early diagnosis of cardiopulmonary disorders along with enhanced technology expansion on a global scale. The cardiopulmonary test examines and detects ischemic heart disease, heart failures, shortness of breath and other pulmonary related disorders. The personalized health medical technology enterprises in the U.S. and Europe are gaining traction in the marketplace. Increasing FDA approvals for new devices with enhanced features and adoption of high-cost systems in the emerging nations will drive the demand during the forecast period. For e.g. in May 2019, the U.S. FDA approved the world's first available six-lead personal electrocardiogram device, KardiaMobile 6L (by AliveCor). This FDA clearance gives physicians or doctors more detailed interpretation into patients' hearts, comprising visibility into positive arrhythmias. 

Topmost companies are focusing on new product development and FDA clearance, mainly in the portable and wireless segment. The growing number of partnerships and agreements with academic research centers and by key public health institutes internationally will drive the overall growth. The global market is also facing the beginning of emerging companies at an exponential growth rate (from Europe and the Asia Pacific) that are competing to develop high-value, economical ancillary devices for numerous stress testing systems. The leading position of North America is due to factors such as swift adoption of breakthrough medical technologies in the region, intensive R&D initiatives and significant pool of incontinence patients. 

Key Market Movements: 

Browse full report at https://www.credenceresearch.com/report/cardiopulmonary-stress-testing-systems-market

The Global Cardiopulmonary Stress Testing Systems Market is Segmented into:

ATTRIBUTE DETAILS
Research Period  2017-2027
Base Year 2018
Forecast Period  2019-2027
Historical Year  2017
Unit  USD Million
Segmentation

 By Product Type (2017–2027; US$ Mn)

 By End-User Segment (2017–2027; US$ Mn)

 By Geography Segment (2017–2027; US$ Mn)

*Complete segmentation list is on report page

Request Sample

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
(US/CANADA) Ph.: +1-800-361-8290
E-mail: sales@credenceresearch.com


Contact Information
24/7 Research Support
Phone: +1-800-361-8290
sales@credenceresearch.com
Get in Touch with us
Join us on Facebook
Follow us on Twitter
Join us on LinkedIn